Deerfield Management’s Cogent Biosciences COGT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $19M | Buy |
2,640,215
+6,353
| +0.2% | +$45.6K | 0.34% | 49 |
|
|
2025
Q1 | $15.8M | Buy |
2,633,862
+2,862
| +0.1% | +$17.1K | 0.31% | 55 |
|
|
2024
Q4 | $20.5M | Sell |
2,631,000
-1,113,263
| -30% | -$8.68M | 0.39% | 50 |
|
|
2024
Q3 | $40.4M | Hold |
3,744,263
| – | – | 0.6% | 35 |
|
|
2024
Q2 | $31.6M | Buy |
3,744,263
+2,209,918
| +144% | +$18.6M | 0.53% | 41 |
|
|
2024
Q1 | $10.3M | Buy |
1,534,345
+445,000
| +41% | +$2.99M | 0.18% | 65 |
|
|
2023
Q4 | $6.41M | Hold |
1,089,345
| – | – | 0.12% | 58 |
|
|
2023
Q3 | $10.6M | Sell |
1,089,345
-2,277,000
| -68% | -$22.2M | 0.23% | 55 |
|
|
2023
Q2 | $39.9M | Buy |
3,366,345
+400,000
| +13% | +$4.74M | 0.85% | 32 |
|
|
2023
Q1 | $32M | Hold |
2,966,345
| – | – | 0.71% | 39 |
|
|
2022
Q4 | $34.3M | Hold |
2,966,345
| – | – | 0.71% | 43 |
|
|
2022
Q3 | $44.3M | Sell |
2,966,345
-2,910,460
| -50% | -$43.4M | 0.88% | 37 |
|
|
2022
Q2 | $53M | Buy |
5,876,805
+4,275,805
| +267% | +$38.6M | 1.09% | 30 |
|
|
2022
Q1 | $12M | Hold |
1,601,000
| – | – | 0.27% | 66 |
|
|
2021
Q4 | $13.7M | Hold |
1,601,000
| – | – | 0.29% | 73 |
|
|
2021
Q3 | $13.5M | Hold |
1,601,000
| – | – | 0.26% | 84 |
|
|
2021
Q2 | $13M | Buy |
1,601,000
+601,000
| +60% | +$4.87M | 0.23% | 102 |
|
|
2021
Q1 | $8.78M | Hold |
1,000,000
| – | – | 0.18% | 107 |
|
|
2020
Q4 | $11.2M | Buy |
+1,000,000
| New | +$11.2M | 0.22% | 97 |
|